Legal & General Group
XBIT icon

Legal & General Group’s XBiotech XBIT Stock Holding History

Legal & General Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,598
Closed -$5.18K – 3555
2025
Q1 		$5.18K Hold
1,598
– – ﹤0.01% 3275
2024
Q4 		$6.31K Hold
1,598
– – ﹤0.01% 3320
2024
Q3 		$12.4K Hold
1,598
– – ﹤0.01% 3231
2024
Q2 		$8.14K Buy
+1,598
New +$12.3K ﹤0.01% 3334
2022
Q3 		– Sell
-1,257
Closed -$7K – 3492
2022
Q2 		$7K Sell
1,257
-3,771
-75% -$25.4K ﹤0.01% 3422
2022
Q1 		$43K Hold
5,028
– – ﹤0.01% 3025
2021
Q4 		$56K Hold
5,028
– – ﹤0.01% 3011
2021
Q3 		$65K Buy
5,028
+3,623
+258% +$57.7K ﹤0.01% 2921
2021
Q2 		$23K Sell
1,405
-949
-40% -$16.1K ﹤0.01% 3251
2021
Q1 		$41K Buy
2,354
+1,097
+87% +$20.5K ﹤0.01% 2885
2020
Q4 		$20K Hold
1,257
– – ﹤0.01% 3096
2020
Q3 		$24K Sell
1,257
-628
-33% -$10.8K ﹤0.01% 2928
2020
Q2 		$26K Sell
1,885
-220
-10% -$3.09K ﹤0.01% 2957
2020
Q1 		$22K Sell
2,105
-1,891
-47% -$30.8K ﹤0.01% 2884
2019
Q4 		$75K Buy
3,996
+380
+11% +$4.89K ﹤0.01% 2686
2019
Q3 		$38K Buy
3,616
+834
+30% +$6.79K ﹤0.01% 2859
2019
Q2 		$21K Buy
+2,782
New +$24.2K ﹤0.01% 3181
2018
Q2 		– Sell
-2,821
Closed -$15K – 3389
2018
Q1 		$15K Sell
2,821
-2,702
-49% -$12.4K ﹤0.01% 3165
2017
Q4 		$22K Hold
5,523
– – ﹤0.01% 3132
2017
Q3 		$24K Hold
5,523
– – ﹤0.01% 3123
2017
Q2 		$26K Hold
5,523
– – ﹤0.01% 3086
2017
Q1 		$93K Hold
5,523
– – ﹤0.01% 2588
2016
Q4 		$56K Buy
5,523
+2,548
+86% +$33.9K ﹤0.01% 2856
2016
Q3 		$38K Hold
2,975
– – ﹤0.01% 2648
2016
Q2 		$60K Buy
+2,975
New +$42.9K ﹤0.01% 2381

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Legal & General Group's XBIT Position: Q2 2025 in Review

Legal & General Group sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 1,598 shares — an estimated $5.18K sold.

Legal & General Group first reported a position in XBIT in Q2 2016 and held it in 25 quarters. The position peaked at $93K in Q1 2017. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • Legal & General Group reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 1,598 XBiotech shares in Q2 2025, an estimated $5.18K.
  • Legal & General Group first reported a position in XBiotech in Q2 2016 and held it in 25 quarters.
  • Legal & General Group's XBiotech position peaked at $93K in Q1 2017.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.